Before You Invest In Plus Therapeutics Inc. (NASDAQ:PSTV), Consider This Metric

Stocks of Plus Therapeutics Inc. (NASDAQ:PSTV) traded higher last session on Wall Street, down -53.54% to $1.38. According to the data, Plus Therapeutics Inc. (NASDAQ:PSTV) has 4 analysts covering its stock. The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $32.00 and […]